Shilpa Medicare Hits Day High After Drug Approval
Shilpa Medicare shares touched a day high on 11 September, after the company secured regulatory approval for a new anti-nausea injection. The rally followed news...
Tag : Shilpa Medicare
Shilpa Medicare Shares Jump 16% on Record Q1 Results
Shilpa Medicare shares hit a record high of Rs 753.85 on the NSE after the company posted record Q1 revenue and profit. The company reported...
Shilpa Medicare Shares Surge 5% on Securing EIR from USFDA
Shares of Shilpa Medicare Ltd were trading almost 5% higher on 15 May after the company secured an Establishment Inspection Report (EIR) from the United...
Shilpa Medicare Shares Gain 4% as Arm Secures EU GMP Clearance
Shares of Shilpa Medicare Ltd were trading in the green and 4% higher on 5 May after the company’s Dharwad plant gained EU GMP clearance....
Shilpa Medicare Rallies 10% as Unit Partners with Swiss Firm for Cancer Drug
Shares of Shilpa Medicare Ltd surged 10% to hit the day’s high of Rs 710.90 on 18th March after the company announced that its subsidiary,...
Shilpa Medicare-Zydus Lifesciences JV Secures USFDA Approval
Shilpa Medicare, in partnership with the Zydus Group through their joint venture Oncosol, and its collaborator Shorla Oncology, announced on November 27 that the USFDA...
Shilpa Medicare Secures API Approval from European Regulator
Shilpa Medicare on Tuesday, 19 November, announced receiving a suitability certificate for its active pharmaceutical ingredient (API), Octreotide, from a European regulatory authority. In its...
Shilpa Medicare Shares Rally 3% as Arm Secures CEP for Desmopressin
Shares of Shilpa Medicare Ltd were trading in the green and 3% higher on 4 October after the company announced that its subsidiary, Shilpa Pharma...
Shilpa Medicare Shares Skyrocketed 11% Successful Phase 3 Clinical Trial
The shares of Shilpa Medicare Ltd skyrocketed 11% on 26 August following the company’s announcement of a positive result in Phase 3 trials for SMLNUD07,...
Shilpa Medicare Bio-Analytical Laboratory Cleared with Zero Observations
Shilpa Medicare, on Tuesday, 25 June, announced that the US Food and Drug Administration (FDA) has successfully concluded an inspection of the company’s Bio-Analytical Laboratory,...